Publication | Closed Access
Retreatment With Omalizumab Results in Rapid Remission in Chronic Spontaneous and Inducible Urticaria
152
Citations
12
References
2014
Year
Omalizumab retreatment is effective and safe in patients with chronic urticaria who have benefited from initial omalizumab treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1